Expertise in
1
conditions

Dr. Dorothy Becker

Pediatric Endocrinology
Childrens Hospital Of Pittsburgh
4401 Penn Ave Fl 3, 
Pittsburgh, PA 

Expertise in
1
conditions
Childrens Hospital Of Pittsburgh
4401 Penn Ave Fl 3, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dorothy Becker is a Pediatric Endocrinologist in Pittsburgh, Pennsylvania. Dr. Becker is highly rated in 1 condition, according to our data. Her top areas of expertise are Type 1 Diabetes (T1D) and Obesity in Children.

Her clinical research consists of co-authoring 78 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Endocrinology
Licenses
Specialist in PA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 6 Less Insurance Carriers -

Locations

Childrens Hospital of Pittsburgh
4401 Penn Ave Fl 3, Pittsburgh, PA 15224
Call: 412-692-5325
Other Locations
Office
3705 5th Ave Rm 4A330, Pittsburgh, PA 15213
Call: 412-692-5170

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes
Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 20, 2025
Intervention Type: Other, Drug
Study Drugs: Pre-Proinsulin, TGF-Beta1, IL-10, IL-2
Study Phase: Phase 1
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes
Enrollment Status: Completed
Publish Date: June 06, 2024
Intervention Type: Drug
Study Drug: CTLA4-Ig (Abatacept)
Study Phase: Phase 2
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
AntiCD3 Mab (Teplizumab) For Prevention of Diabetes In Relatives At-Risk for Type 1 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: August 05, 2020
Intervention Type: Drug
Study Phase: Phase 2
Exploring Immunologic Effects of Oral Insulin in Relatives at Risk for Type 1
Exploring Immunologic Effects of Oral Insulin in Relatives at Risk for Type 1
Enrollment Status: Completed
Publish Date: July 27, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

78 Total Publications

Hydroxychloroquine in Stage 1 Type 1 Diabetes.
Hydroxychloroquine in Stage 1 Type 1 Diabetes.
Journal: Diabetes care
Published: June 14, 2023
View All 78 Publications
Similar Doctors
Expertise in
2
conditions
Dr. Ingrid Libman
Pediatric Endocrinology
Expertise in
2
conditions
Dr. Ingrid Libman
Pediatric Endocrinology

UPMC Children's Hospital Of Pittsburgh

4401 Penn Ave, 
Pittsburgh, PA 
 (1.8 miles away)
412-692-5325
Languages Spoken:
English
See accepted insurances

Ingrid Libman is a Pediatric Endocrinologist in Pittsburgh, Pennsylvania. Dr. Libman is highly rated in 2 conditions, according to our data. Her top areas of expertise are Type 1 Diabetes (T1D), Obesity in Children, Wilson Disease, and Non-Alcoholic Fatty Liver Disease.

Expertise in
4
conditions
Dr. Hala Tfayli
Pediatric Endocrinology
Expertise in
4
conditions
Dr. Hala Tfayli
Pediatric Endocrinology

Office

200 Lothrop St Ste 9055, 
Pittsburgh, PA 
 (0.3 miles away)
412-692-5170
Languages Spoken:
English
See accepted insurances

Hala Tfayli is a Pediatric Endocrinologist in Pittsburgh, Pennsylvania. Dr. Tfayli is highly rated in 4 conditions, according to our data. Her top areas of expertise are Obesity in Children, Congenital Hyperinsulinism, Type 2 Diabetes (T2D), and Obesity.

Mary E. Vajravelu
Expertise in
6
conditions
Dr. Mary E. Vajravelu
Pediatric Endocrinology
Expertise in
6
conditions
Dr. Mary E. Vajravelu
Pediatric Endocrinology

Pediatric Endocrinology In Lawrenceville

4401 Penn Avenue, 
Pittsburgh, PA 
 (1.8 miles away)
412-692-5170
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mary Vajravelu, MD, is certified in pediatrics and pediatric endocrinology by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh, Pediatric Endocrinology and is affiliated with UPMC Children's Hospital of Pittsburgh. She completed her fellowship and residency at Children's Hospital of Philadelphia and medical degree at Case Western Reserve University School of Medicine. Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule. Dr. Vajravelu is highly rated in 6 conditions, according to our data. Her top areas of expertise are Congenital Hyperinsulinism, Newborn Low Blood Sugar, Obesity in Children, and Low Blood Sugar.

VIEW MORE Pediatric Endocrinologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Becker's expertise for a condition
ConditionClose
  • Elite
  • Type 1 Diabetes (T1D)
    Dr. Becker is
    Elite
    . Learn about Type 1 Diabetes (T1D).
    See more Type 1 Diabetes (T1D) experts
      • Experienced
      • Obesity in Children
        Dr. Becker is
        Experienced
        . Learn about Obesity in Children.
        See more Obesity in Children experts
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      1. Homepage
      2. Pediatric Endocrinologists Pittsburgh, PA
      3. Dr. Dorothy Becker
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.